Monographie - Deferoxamine mesylate

Ultimo aggiornamento :
08/05/2024

Deferoxamine mesylate

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Deferoxamina	Spagna
Deferoxamine mesylate	Canada, Stati Uniti d’America
Deferoxaminmesilat	Germania
Desferal	Arabia Saudita, Argentina, Australia, Austria, Belgio, Canada, Chile, Colombia, Danimarca, Egitto, Finlandia, Francia, Germania, Gran Bretagna, Grecia, India, Iran, Irlanda, Islanda, Italia, Lussemburgo, Malaysia, Marocco, Messico, Norvegia, Paesi Bassi, Polonia, Portogallo, Romania, Stati Uniti d’America, Svezia, Svizzera, Tunisia, Turchia, Ungheria, Venezuela
Desferin	Danimarca, Spagna
Desferioxamine mesilate	Gran Bretagna
Desfonak	Iran
PMS desferoxamine	Canada
Talifer	Messico

Bibliografia : Deferoxamine mesylate

	Tipo	Pubblicazione
5	Rivista	Stiles ML, Allen LV Jr, Prince SJ. Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Am J Health-Syst Pharm 1996 ; 53: 1583-1588.
604	Laboratorio	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
960	Rivista	Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N. Stability of aqueous solutions of deferoxamine. Can J Hosp Pharm 1990 ; 43: 57-60.
1669	Rivista	Hayes DM, Reilly RM, Lee MMC. The pharmaceutical stability of deferoxamine mesylate. Can J Hosp Pharm 1994 ; 47: 9-14.
2156	Rivista	Kane MP, Bailie GR, Moon DG, Siu I. Stability of deferoxamine peritoneal dialysate solutions. Perit Dial Int 1994 ; 14: 396-398.
3671	Laboratorio	Deferoxamine - Résumé des caractéristiques du produit Teva UK Ltd 2016
3728	Rivista	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.

Mentions Légales